" Janice Shih might be the most educated pastry chef you'll ever meet. Shih attended Johns Hopkins University, followed by medical school at George Washington University, then practiced for eight years as an...
created by sweet east pearl | 1 year ago | updated 1 year ago 217 views | 5 recommendations | 2 comments
" flexible but resilient gel that could be used as artificial cartilage to repair ailing joints is being investigated by US researchers. Made from polymers commonly found in shampoo, the water-based gel could help people with joint diseases like arthritis – a disease...
created by JonBaker | 1 year ago 247 views | 0 recommendations | 0 comments
""Based upon its impressive capabilities, we believe MaxCyte's cell loading technology can be an important component of our closed system," said Baek Chun Lee, Ph.D., Binex's Chairman. "Our immunotherapy product is currently undergoing review by the Korean FDA for colorectal...
created by uusjio | 1 year ago 252 views | 0 recommendations | 0 comments
"Approximately, 5-10 per cent of all colorectal cancers occur in people who are at "high risk," defined as much greater than twice the average risk. An additional 15-20 per cent of colorectal cancers occur in people at "increased risk," defined as approximately twice average...
created by uusjio | 1 year ago 228 views | 0 recommendations | 0 comments
"Breast cancer is the most common type of cancer in women accounting for 26 per cent of female cancers. One in every eight women will develop breast cancer in their lifetime, placing the lifetime risk at 13 per cent. More than 200,000 new cases of breast cancer will be...
created by uusjio | 2 years ago 158 views | 0 recommendations | 0 comments
Medimmune's Motavizumab Reduced Rsv Hospitalizations by 83 Percent
Among High-Risk Native American, Full-Term Infants in
Placebo-Controlled Phase 3 study
(Full text of a statement. Contact details follow below.)
Gaithersburg, Md. (ANTARA News/PRNewswire-AsiaNet) -...
created by uusjio | 2 years ago 283 views | 0 recommendations | 0 comments